Evidence map›Paper›PMID 34959667›Full record

ReviewPharmaceuticals (Basel, Switzerland)2021

Quorum Sensing Inhibitors to Quench

Marine Duplantier, Elodie Lohou, Pascal Sonnet

Open access · goldAbstract readReview
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.

  1. Understanding bacterial biofilms: From definition to treatment strategies.Frontiers in cellular and infection microbiology · 2023
    Pooled it
  2. Characterization of a Novel Quorum QuencherPlants (Basel, Switzerland) · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Role of cell-associated and secretion-independent virulence factors of Pseudomonas aeruginosa in microbial keratitis and anti-virulence therapeutic strategies.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Broadly Defined Antibiotic Adjuvants forThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Anti-QS Strategies AgainstMicroorganisms · 2025
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Marine DuplantierAGIR, UR4294, UFR of Pharmacy, Jules Verne University of Picardie, 80037 Amiens, France.ORCID 0000-0002-4826-2283
Elodie LohouAGIR, UR4294, UFR of Pharmacy, Jules Verne University of Picardie, 80037 Amiens, France.
Pascal SonnetAGIR, UR4294, UFR of Pharmacy, Jules Verne University of Picardie, 80037 Amiens, France.ORCID 0000-0003-0118-9151
Agents infectieux, résistance et chimiothérapie · FR

Funding

Ministere de l'Enseignement Superieur, de la Recherche et de l'Innovation 18004360Région Hauts-de-France 18004360
6 · The paper itself

Abstract

The emergence and the dissemination of multidrug-resistant bacteria constitute a major public health issue. Among incriminated Gram-negative bacteria,

Indexed as

anti-bioresistanceanti-virulence strategybacterial communication systemsbiofilmsPseudomonas aeruginosaquorum sensingquorum sensing inhibitorsvirulence factors

Identifiers

PMID34959667
PMCPMC8707152
OpenAlexW4200612589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.